20–23 Sept 2023
Metropol Lake Resort, Ohrid
Europe/Skopje timezone

Fermentation – from food industry by-products valorization to neurotransmitters production

Not scheduled
20m
Metropol Lake Resort, Ohrid

Metropol Lake Resort, Ohrid

Oral presentation

Speaker

Elena Bartkiene (Lithuanian University of Health Sciences)

Description

Lactic acid bacteria (LAB) are employed as a biotechnological starters to improve the safety and functionality of food and feed, to provide added value and to increase safety of food industry by-products (to reduce mycotoxins, acrylamide, polycyclic hydrocarbons, etc., concentration), to design synthesis of functional molecules (e.g., vitamins, free amino acids, volatile compounds, fatty acids, etc.) in fermentable substrates, to moderate the technologies for safer alternative stock (e.g., insect flour, algae biomass, savory plants) incorporation to the main food (e.g., bread, cheese, etc.) formulas, to perform conversion of microalgae to valuable molecules possessing neurotransmitters characteristics. Metabolic activity of the LAB strongly affects the characteristics of the fermentable substrate. The addition of starter cultures under controlled conditions is a highly prospective technology for sustainable food and feed materials preparation. Metabolites of the LAB as well as viable LAB cells in fermented materials leads to desirable changes in mammals digestive tract microbiota in vivo, which leads to better health. Additionally, the high-functionality fermented food ingredients can be produced by applying LAB for the food industry by-product valorization. Also, fermentation with LAB greatly contribute not only to the flavour, aroma, and texture of the final product but also to functional molecules synthesis, e.g., galactooligosaccharides can be synthesized from the dairy industry by-products containing lactose; gamma-aminobutyric acid (GABA) can be produced from the substrates containing L-glutamic acid (e.g., Spirulina). Additionally, LAB can excrete precursors (L-glutamic acid) for further GABA production in vivo. This type of bioconversion is a very promising technology for food, feed, nutraceuticals, pharmaceuticals, and supplements production. Finally, our works showed, that LAB application in industry is extremely broad: from food industry by-products valorization to neurotransmitters production.

Acknowledgments: The authors gratefully acknowledge COST Action 18101 SOURDOMICS—Sourdough biotechnology network towards novel, healthier and sustainable food and bioprocesses (https://sourdomics.com/; https://www.cost.eu/actions/CA18101/); Lithuanian – Bulgarian joint research project “Selection of microorganisms for industrial biotechnology purposes according to their specific metabolites profile by using sustainable substrates for active compounds preparation” under the agreement on scientific cooperation between the Lithuanian Academy of Sciences and the Bulgarian Academy of Sciences; EUREKA Network Project E!13309 “SUSFEETECH” (Nr. 01.2.2-MITA-K-702-05-0001).

Primary author

Elena Bartkiene (Lithuanian University of Health Sciences)

Presentation materials